Connect Sign In
LabMind podcasts
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in July. |
August 2, 2023 |
ARUP Consult Updates Lyme Disease, Pneumonia, and Infertility Testing Resources ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on testing for Lyme disease, diagnosing pneumonia, and evaluating infertility. |
ARUP Chief Medical Officer Jonathan Genzen, MD, PhD, will present insights on workflow, specimen transport, and automation in an American Association for Clinical Chemistry (AACC) 2023 scientific session. |
July 24, 2023 |
ARUP Experts Lead the Way at the 2023 American Association for Clinical Chemistry Meeting ARUP researchers and medical directors will join industry leaders at AACC 2023 to share their expertise on laboratory stewardship, workforce needs, automation, and more. |
ARUP Consult®, a free source of laboratory testing information for clinicians, has updated several resources in June. |
July 6, 2023 |
ARUP Consult Updates Human Papillomavirus, Chronic Lymphocytic Leukemia, and Amenorrhea Resources ARUP Consult, a free source of expert guidance in laboratory testing, has updated resources on testing for human papillomavirus, chronic lymphocytic leukemia, and amenorrhea. |
ARUP Blood Services has aligned its donor eligibility assessment processes to follow recent U.S. Food and Drug Administration (FDA) guideline updates, and the changes will take effect on July 18, 2023. |
July 5, 2023 |
ARUP Blood Services Implements Changes in Response to New FDA Guidelines on Blood Donor Assessment The FDA now recommends the same assessment questions for all donors, regardless of gender or sexual orientation. ARUP Blood Services is one of the first donor centers to update processes in response. |
ARUP’s new test is the first companion diagnostic immunoassay for a gene therapy product to receive FDA approval. FDA has issued simultaneous approval of ROCTAVIAN™ (valoctocogene roxaparvovec-rvox), BioMarin’s gene therapy for severe hemophilia A. |
June 29, 2023 | ARUP Laboratories has received FDA approval for its companion diagnostic immunoassay, AAV5 DetectCDx™, which helps determine patient eligibility for a new gene therapy for severe hemophilia A. |
ARUP Laboratories’ Access and Reimbursement Manager Valerie Collier, MS, CGC, will be featured as an expert panelist in a special upcoming Dark Report webinar on June 29. |
June 23, 2023 |
ARUP Expert to Present Insights on Obtaining Z-Codes in Special Dark Report Webinar Valerie Collier, MS, CGC, will present insights on the DEX MolDx program and how to submit Z-Code applications under new private payer Z-Code requirements as an expert panelist in an upcoming webinar. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat